These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 25496326)
1. SmI2-mediated radical coupling strategy to Securinega alkaloids: total synthesis of (-)-14,15-dihydrosecurinine and formal total synthesis of (-)-securinine. Zheng X; Liu J; Ye CX; Wang A; Wang AE; Huang PQ J Org Chem; 2015 Jan; 80(2):1034-41. PubMed ID: 25496326 [TBL] [Abstract][Full Text] [Related]
3. Enantioselective approach to Securinega alkaloids. Total synthesis of securinine and (-)-norsecurinine. González-Gálvez D; García-García E; Alibés R; Bayón P; de March P; Figueredo M; Font J J Org Chem; 2009 Aug; 74(16):6199-211. PubMed ID: 19627163 [TBL] [Abstract][Full Text] [Related]
4. A new general access to either type of Securinega alkaloids: synthesis of securinine and (-)-allonorsecurinine. Alibés R; Ballbé M; Busqué F; de March P; Elias L; Figueredo M; Font J Org Lett; 2004 May; 6(11):1813-6. PubMed ID: 15151421 [TBL] [Abstract][Full Text] [Related]
5. Viability of a [2 + 2 + 1] Hetero-Pauson-Khand Cycloaddition Strategy toward Securinega Alkaloids: Synthesis of the BCD-Ring Core of Securinine and Related Alkaloids. Chirkin E; Michel S; Porée FH J Org Chem; 2015 Jul; 80(13):6525-8. PubMed ID: 26098882 [TBL] [Abstract][Full Text] [Related]
6. Diastereoselective synthesis of allosecurinine and viroallosecurinine from menisdaurilide. Bardají GG; Cantó M; Alibés R; Bayón P; Busqué F; de March P; Figueredo M; Font J J Org Chem; 2008 Oct; 73(19):7657-62. PubMed ID: 18781804 [TBL] [Abstract][Full Text] [Related]
7. An effective enantioselective approach to the securinega alkaloids: total synthesis of (-)-norsecurinine. Alibés R; Bayón P; de March P; Figueredo M; Font J; García-García E; González-Gálvez D Org Lett; 2005 Oct; 7(22):5107-9. PubMed ID: 16235969 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new securinine analogues as potential anticancer agents. Perez M; Ayad T; Maillos P; Poughon V; Fahy J; Ratovelomanana-Vidal V Eur J Med Chem; 2016 Feb; 109():287-93. PubMed ID: 26793989 [TBL] [Abstract][Full Text] [Related]
9. Chiroptical study and absolute configuration of securinine oxidation products. Chirkin E; Atkatlian W; Do Q; Gaslonde T; Dufat TH; Michel S; Lemoine P; Genta-Jouve G; Porée FH Nat Prod Res; 2015; 29(13):1235-42. PubMed ID: 25790256 [TBL] [Abstract][Full Text] [Related]
10. An approach to the skeleton of the securinega alkaloids. The total synthesis of (+/-)-securinine. Liras S; Davoren JE; Bordner J Org Lett; 2001 Mar; 3(5):703-6. PubMed ID: 11259041 [TBL] [Abstract][Full Text] [Related]
16. Total syntheses of the Securinega alkaloids (+)-14,15-dihydronorsecurinine, (-)-norsecurinine, and phyllanthine. Han G; LaPorte MG; Folmer JJ; Werner KM; Weinreb SM J Org Chem; 2000 Oct; 65(20):6293-306. PubMed ID: 11052071 [TBL] [Abstract][Full Text] [Related]
17. Total synthesis of securinega alkaloids (-)-norsecurinine, (-)-niruroidine and (-)-flueggine A. Ma N; Yao Y; Zhao BX; Wang Y; Ye WC; Jiang S Chem Commun (Camb); 2014 Aug; 50(66):9284-7. PubMed ID: 25000877 [TBL] [Abstract][Full Text] [Related]
18. [DETERMINATION OF SECURININE AND ITS STEREOISOMERS IN PLANTS OF THE SECURINEGA SPECIES, AND ISOLATION OF VIROALLOSECURININE AND VIROSINE]. SAITO S; TANAKA T; IWAMOTO T; MATSUMURA C; SUGIMOTO N; HORII Z; MAKITA M; IKEDA M; TAMURA Y Yakugaku Zasshi; 1964 Nov; 84():1126-33. PubMed ID: 14265139 [No Abstract] [Full Text] [Related]
19. [Studies on securinine. I. Isolation and correlation of Securinega alkaloids]. HORII ZI; TANAKA T; TAMURA Y; SAITO S; MATSUMURA C; SUGIMOTO N Yakugaku Zasshi; 1963 Jun; 83():602-5. PubMed ID: 13961782 [No Abstract] [Full Text] [Related]
20. [Total synthesis of securinine]. Xi FD; Liang XT Yao Xue Xue Bao; 1992; 27(5):349-52. PubMed ID: 1442055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]